Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 34Observational 4Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 4

Interventions

Gastrectomy 13Observation 12Gastroscopy 11Drug Therapy 9Surveys and Questionnaires 8Surgical Procedures, Operative 8Endoscopic Mucosal Resection 8Paclitaxel 6Immune Checkpoint Inhibitors 6Blood Specimen Collection 6Tomography, X-Ray Computed 5Oxaliplatin 5Trastuzumab 4Ramucirumab 4Irinotecan 4Immunotherapy 4Hyperthermic Intraperitoneal Chemotherapy 4Cisplatin 4Biopsy 4tislelizumab 3S 1 (combination) 3Robotic Surgical Procedures 3Radiotherapy 3Positron Emission Tomography Computed Tomography 3Nivolumab 3Neoadjuvant Therapy 3Laparoscopy 3Interviews as Topic 3Capecitabine 3taxane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Stomach Neoplasms × Ramucirumab × Clear all
NCT06490055 2025-07-18

Predicting the Efficacy in Advanced Gastric Cancer.

City of Hope Medical Center

Completed
162 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06490159 2025-07-11

Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer

City of Hope Medical Center

Recruiting
150 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06666582 2024-10-30

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Hellenic Cooperative Oncology Group

Completed
185 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04915807 2021-06-07

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Hallym University Medical Center

Unknown
222 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡